About the Author
Big Pharma’s New Pill to Swallow: Trade Wars
Pfizer’s CEO Albert Bourla challenges Washington’s tariff plans, urging smarter solutions like tax incentives to secure U.S. pharma dominance.
O Canada, O Gains: Stephen Takacsy’s Great White North Picks for 2025
Canadian Strongholds: Why Stephen Takacsy Is Betting Big on EQB, Altus Group, and Tecsys Amid Global Turmoil
Private Equity Firms Are Betting Big on Europe's Military Surge
Private equity storms into Europe's defense sector, flipping the script on decades of taboo investments.
Brian Madden’s Market GPS: Crops, Clinics, and Cockpits
Unlocking Value in Volatile Markets: Why Brian Madden Believes Nutrien, UnitedHealth, and Bombardier Are Ready to Soar
From Spin to Win: Peloton’s Back, Spotify’s Up Next
Peloton regains Wall Street’s favor while Spotify braces for a critical earnings report amid shifting economic tides.
Strike While the Mines are Hot: Alkane and Mandalay’s Big Bet on a Game-Changing Merger
A Bold New Chapter Begins as Alkane Resources and Mandalay Resources Forge a Gold and Antimony Powerhouse
Why Is Ashley Zumwalt-Forbes the Name to Watch in Critical Minerals?
How Ashley Zumwalt-Forbes Is Redefining the Future of Critical Minerals
Rock Solid Strategy: Trump Drills Into China’s Supply Chains
Inside Trump’s High-Stakes Plan to Reclaim America’s Mineral Independence from China’s Global Stronghold
Made in China, Lost in Combat: The U.S. War Machine’s Fatal Flaw
America’s War Chest Is Running on Fumes—and Silicon Valley’s Defense Elite Is Sounding the Alarm
Trump’s Royal Flush: Nevada’s Critical Minerals Take Center Stage
How Trump’s America-First Policies Are Turning Nevada’s Minerals into a Winning Hand